Author： Fakra Eric Azorin Jean-Michel
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.13, 2012-09, pp. : 1923-1935
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clozapine treatment of young subjects affected with schizophrenia
By Bruno V.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Access to resources
Recommend
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
By Bitter I. Dossenbach M.R.K. Brook S. Feldman P.D. Metcalfe S. Gagiano C.A. Furedi J. Bartko G. Janka Z. Banki C.M. Kovacs G. Breier A. for the Olanzapine HGCK Study Group
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. :
Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. :